Related Experiment Video
Updated: Feb 26, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Insomnia and stroke risk: A systematic review with meta-analysis of analytical observational studies and mendelian
Miguel Cabanillas-Lazo1, Milagros Pascual-Guevara1, Gustavo Tapia-Sequeiros2
1Grupo de Investigación Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria (NEMECS), Universidad Científica del Sur, Lima, 15001, Peru.
Abstract:
Stroke is one of the leading causes of death worldwide, with ischemic stroke being the most frequent subtype. Factors such as sleep disorders may increase the risk of stroke; however, solid evidence is lacking. Therefore, the objective was to synthesize current evidence on the relationship between insomnia and its role as a risk factor for stroke. A systematic review and meta-analysis were conducted, with searches performed in PubMed, Embase, Scopus, Google Scholar, and Web of Science up to March 2024. The included studies were observational or Mendelian randomized studies that evaluated the diagnosis or symptoms of insomnia and any type of stroke as an outcome. The study selection process, data extraction, and risk of bias assessment were conducted in pairs. A random-effects meta-analysis was performed to estimate the effect of the outcome. Trial Registration: PROSPERO CRD42024519745. A total of 17 studies (12 observational studies and 5 Mendelian randomization studies) were analyzed, representing a total population of 7,696,920 patients. In the pooled analysis, no significant association was observed between the risk of developing any type of stroke and the presence of any insomnia symptom (HR: 1.16; 95% CI: 0.88-1.52; I2 = 60%), but a higher risk of developing ischemic stroke was found (HR: 1.07; 95% CI: 1.04-1.10; I2 = 60%) with a high level of evidence certainty. Conversely, an increased risk of any type of stroke was observed when insomnia was diagnosed (HR: 1.45; 95% CI: 1.32-1.61).
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Blind Procedures